SARAJEVO (Bosnia and Herzegovina), September 26 (SeeNews) – Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said on Tuesday its net profit fell to 542,271 marka ($327,600/277,300 euro) in the first six months of 2017, from 1.2 million marka a year earlier.
Operating income increased 14.0% to 52.8 million marka in the six months through June, while operating costs climbed 13.9% to 51.1 million marka, Bosnalijek said in a filing with the Sarajevo Stock Exchange.
In October, Bosnia's Federation government sold its 19.3% stake in Bosnalijek for 23.4 million marka to Malta-based financial services provider KBC Euro Credit Capital.
The Federation is one of the two autonomous entities that make up Bosnia and Herzegovina. The other one is the Serb Republic.
(1 euro=1.95583 Bosnian marka)